Zhen Gooi MD
Head & Neck Oncologic Surgery
Surgeon, The Queen's Medical Center Head and Neck Institute
Join to View Full Profile
1380 Lusitana St, Suite 615Honolulu, HI 96813
Phone+1 808-691-7215
Fax+1 808-691-7214
Dr. Gooi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2014 - 2015- Johns Hopkins UniversityResidency, Otolaryngology - Head and Neck Surgery, 2010 - 2014
- Johns Hopkins UniversityResidency, Surgery, 2009 - 2010
(King's College London - School of Medicine)Class of 2008
Certifications & Licensure
HI State Medical License 2025 - 2028
IL State Medical License 2015 - 2026
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
Publications & Presentations
PubMed
- 3 citationsEarly Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer.Ari J Rosenberg, Evgeny Izumchenko, Aditya Juloori, Rohan Katipally, John Cursio
Clinical Cancer Research. 2025-08-01 - 16 citationsNeoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized C...Ari J Rosenberg, Aditya Juloori, Michael J Jelinek, Nishant Agrawal, John F Cursio
JAMA Oncology. 2025-05-01 - 31 citationsNeoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial.Ari J Rosenberg, Nishant Agrawal, Aditya Juloori, John Cursio, Zhen Gooi
JAMA Oncology. 2024-07-01
Journal Articles
- OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal CancerL Portugal, E A Blair, J M Melotek, M W Lingen, N Agrawal, A Dekker, Z Gooi, D T Ginat, C C Foster, E E Vokes, D J Haraf, Annals of Oncology
- Head and Neck MassesNishant Agrawal, Zhen Gooi, ScienceDirect
Authored Content
- Surgical vs. Medical Management for Obstructive Sleep ApneaAugust 2021
- Effect of Dose Reduction Radiation Treatment in HPV-Associated Oropharyngeal Cancer PatientsMay 2021
- Comparing Management Options of Neck Nodal Regions in Early-Stage Head and Neck CancerApril 2021
Press Mentions
Is Head & Neck Surgery in the Super-Old a Bad Idea?October 9th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
